Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Krystal Biotech, Inc. - Common Stock
(NQ:
KRYS
)
293.87
+17.42 (+6.30%)
Streaming Delayed Price
Updated: 1:34 PM EST, Feb 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Krystal Biotech, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
↗
March 05, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
↗
March 01, 2024
It will take a lot, but this goal isn't out of reach for these stocks.
Via
The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $7,400 Today
↗
February 29, 2024
Via
Benzinga
Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results
↗
February 27, 2024
Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday.
Via
Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
February 26, 2024
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
February 26, 2024
Via
Benzinga
Krystal Biotech Inc. (NASDAQ: KRYS) is a Leading Gainer in 2/26 Morning Trading
February 26, 2024
Via
Investor Brand Network
Earnings Scheduled For February 26, 2024
↗
February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.
Via
Benzinga
A Preview Of Krystal Biotech's Earnings
↗
February 23, 2024
Via
Benzinga
AI, Biotech, Energy Sectors Expect M&A Revival For 2024
↗
January 29, 2024
The AI market, along with energy and biotech, are ripe for M&A following the worst performance in almost a decade for deal-making in 2023.
Via
Benzinga
Topics
Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 16, 2024
Via
Benzinga
Expert Ratings for Krystal Biotech
↗
December 13, 2023
Via
Benzinga
This Stock Has Quadrupled in 5 Years. Can It Do It Again?
↗
November 10, 2023
Have investors already missed the boat with this stock?
Via
The Motley Fool
Earnings Scheduled For November 6, 2023
↗
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
A Preview Of Krystal Biotech's Earnings
↗
November 03, 2023
Via
Benzinga
5 Analysts Have This to Say About Krystal Biotech
↗
October 12, 2023
Via
Benzinga
5 Analysts Have This to Say About Krystal Biotech
↗
September 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
↗
October 24, 2023
Via
Benzinga
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
↗
September 15, 2023
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.
Via
Investor's Business Daily
Analyst Ratings for Krystal Biotech
↗
August 08, 2023
Via
Benzinga
Expert Ratings for Krystal Biotech
↗
July 03, 2023
Via
Benzinga
What Will AbbVie Buy Next?
↗
June 28, 2023
Two mid-cap drugmakers stand out as logical targets for AbbVie.
Via
The Motley Fool
Krystal Biotech Inc. (NASDAQ: KRYS) is a Stock Spotlight on 6/8
June 08, 2023
Via
Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
↗
October 12, 2023
Via
Benzinga
Krystal Biotech Sells Rare Pediatric Disease Priority Review Voucher For $100M
↗
August 21, 2023
Krystal Biotech, Inc. (NASDAQ: KRYS) has completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV)
Via
Benzinga
3 Biotech Stocks to Buy Before the Breakout
↗
July 28, 2023
Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
↗
September 07, 2023
Via
Benzinga
2 Soaring Stocks With More Upside Potential
↗
July 21, 2023
Are these mid-cap stocks giants in the making?
Via
The Motley Fool
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
August 07, 2023
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...
Via
Benzinga
Arbutus Appoints Two New Executives
July 10, 2023
From
Arbutus Biopharma Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
